Acadia Exponential Volume In Stock & Options (ACAD)

Posted in General, Options 
August 13th, 2009

Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) shares are exploding 17% higher and September calls are trading more than 11,000 contracts with buyers in the $10′s and $12.50′s as shares cross $6.25.  Top line results for its Parkinson’s drug is expected by the end of Q3 for pimavanserin.  Update: as of 12:12 shares are up 17% and the volume is already twice normal at over 2 million shares vs. average volume of $925,000 shares.  52-week range is $0.72 to $6.40. 

-Joe Kunkle, OptionsHawk.com

Comments are closed

-->